Cargando…
Prognosis of Patients with Hepatocellular Carcinoma. Validation and Ranking of Established Staging-Systems in a Large Western HCC-Cohort
BACKGROUND: HCC is diagnosed in approximately half a million people per year, worldwide. Staging is a more complex issue than in most other cancer entities and, mainly due to unique geographic characteristics of the disease, no universally accepted staging system exists to date. Focusing on survival...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465308/ https://www.ncbi.nlm.nih.gov/pubmed/23071507 http://dx.doi.org/10.1371/journal.pone.0045066 |
_version_ | 1782245551704637440 |
---|---|
author | op den Winkel, Mark Nagel, Dorothea Sappl, Julia op den Winkel, Philip Lamerz, Rolf Zech, Christoph J. Straub, Gundula Nickel, Thomas Rentsch, Markus Stieber, Petra Göke, Burkhard Kolligs, Frank T. |
author_facet | op den Winkel, Mark Nagel, Dorothea Sappl, Julia op den Winkel, Philip Lamerz, Rolf Zech, Christoph J. Straub, Gundula Nickel, Thomas Rentsch, Markus Stieber, Petra Göke, Burkhard Kolligs, Frank T. |
author_sort | op den Winkel, Mark |
collection | PubMed |
description | BACKGROUND: HCC is diagnosed in approximately half a million people per year, worldwide. Staging is a more complex issue than in most other cancer entities and, mainly due to unique geographic characteristics of the disease, no universally accepted staging system exists to date. Focusing on survival rates we analyzed demographic, etiological, clinical, laboratory and tumor characteristics of HCC-patients in our institution and applied the common staging systems. Furthermore we aimed at identifying the most suitable of the current staging systems for predicting survival. METHODOLOGY/PRINCIPAL FINDINGS: Overall, 405 patients with HCC were identified from an electronic medical record database. The following seven staging systems were applied and ranked according to their ability to predict survival by using the Akaike information criterion (AIC) and the concordance-index (c-index): BCLC, CLIP, GETCH, JIS, Okuda, TNM and Child-Pugh. Separately, every single variable of each staging system was tested for prognostic meaning in uni- and multivariate analysis. Alcoholic cirrhosis (44.4%) was the leading etiological factor followed by viral hepatitis C (18.8%). Median survival was 18.1 months (95%-CI: 15.2–22.2). Ascites, bilirubin, alkaline phosphatase, AFP, number of tumor nodes and the BCLC tumor extension remained independent prognostic factors in multivariate analysis. Overall, all of the tested staging systems showed a reasonable discriminatory ability. CLIP (closely followed by JIS) was the top-ranked score in terms of prognostic capability with the best values of the AIC and c-index (AIC 2286, c-index 0.71), surpassing other established staging systems like BCLC (AIC 2343, c-index 0.66). The unidimensional scores TNM (AIC 2342, c-index 0.64) and Child-Pugh (AIC 2369, c-index 0.63) performed in an inferior fashion. CONCLUSIONS/SIGNIFICANCE: Compared with six other staging systems, the CLIP-score was identified as the most suitable staging system for predicting prognosis in a large German cohort of predominantly non-surgical HCC-patients. |
format | Online Article Text |
id | pubmed-3465308 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-34653082012-10-15 Prognosis of Patients with Hepatocellular Carcinoma. Validation and Ranking of Established Staging-Systems in a Large Western HCC-Cohort op den Winkel, Mark Nagel, Dorothea Sappl, Julia op den Winkel, Philip Lamerz, Rolf Zech, Christoph J. Straub, Gundula Nickel, Thomas Rentsch, Markus Stieber, Petra Göke, Burkhard Kolligs, Frank T. PLoS One Research Article BACKGROUND: HCC is diagnosed in approximately half a million people per year, worldwide. Staging is a more complex issue than in most other cancer entities and, mainly due to unique geographic characteristics of the disease, no universally accepted staging system exists to date. Focusing on survival rates we analyzed demographic, etiological, clinical, laboratory and tumor characteristics of HCC-patients in our institution and applied the common staging systems. Furthermore we aimed at identifying the most suitable of the current staging systems for predicting survival. METHODOLOGY/PRINCIPAL FINDINGS: Overall, 405 patients with HCC were identified from an electronic medical record database. The following seven staging systems were applied and ranked according to their ability to predict survival by using the Akaike information criterion (AIC) and the concordance-index (c-index): BCLC, CLIP, GETCH, JIS, Okuda, TNM and Child-Pugh. Separately, every single variable of each staging system was tested for prognostic meaning in uni- and multivariate analysis. Alcoholic cirrhosis (44.4%) was the leading etiological factor followed by viral hepatitis C (18.8%). Median survival was 18.1 months (95%-CI: 15.2–22.2). Ascites, bilirubin, alkaline phosphatase, AFP, number of tumor nodes and the BCLC tumor extension remained independent prognostic factors in multivariate analysis. Overall, all of the tested staging systems showed a reasonable discriminatory ability. CLIP (closely followed by JIS) was the top-ranked score in terms of prognostic capability with the best values of the AIC and c-index (AIC 2286, c-index 0.71), surpassing other established staging systems like BCLC (AIC 2343, c-index 0.66). The unidimensional scores TNM (AIC 2342, c-index 0.64) and Child-Pugh (AIC 2369, c-index 0.63) performed in an inferior fashion. CONCLUSIONS/SIGNIFICANCE: Compared with six other staging systems, the CLIP-score was identified as the most suitable staging system for predicting prognosis in a large German cohort of predominantly non-surgical HCC-patients. Public Library of Science 2012-10-05 /pmc/articles/PMC3465308/ /pubmed/23071507 http://dx.doi.org/10.1371/journal.pone.0045066 Text en © 2012 op den Winkel et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article op den Winkel, Mark Nagel, Dorothea Sappl, Julia op den Winkel, Philip Lamerz, Rolf Zech, Christoph J. Straub, Gundula Nickel, Thomas Rentsch, Markus Stieber, Petra Göke, Burkhard Kolligs, Frank T. Prognosis of Patients with Hepatocellular Carcinoma. Validation and Ranking of Established Staging-Systems in a Large Western HCC-Cohort |
title | Prognosis of Patients with Hepatocellular Carcinoma. Validation and Ranking of Established Staging-Systems in a Large Western HCC-Cohort |
title_full | Prognosis of Patients with Hepatocellular Carcinoma. Validation and Ranking of Established Staging-Systems in a Large Western HCC-Cohort |
title_fullStr | Prognosis of Patients with Hepatocellular Carcinoma. Validation and Ranking of Established Staging-Systems in a Large Western HCC-Cohort |
title_full_unstemmed | Prognosis of Patients with Hepatocellular Carcinoma. Validation and Ranking of Established Staging-Systems in a Large Western HCC-Cohort |
title_short | Prognosis of Patients with Hepatocellular Carcinoma. Validation and Ranking of Established Staging-Systems in a Large Western HCC-Cohort |
title_sort | prognosis of patients with hepatocellular carcinoma. validation and ranking of established staging-systems in a large western hcc-cohort |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465308/ https://www.ncbi.nlm.nih.gov/pubmed/23071507 http://dx.doi.org/10.1371/journal.pone.0045066 |
work_keys_str_mv | AT opdenwinkelmark prognosisofpatientswithhepatocellularcarcinomavalidationandrankingofestablishedstagingsystemsinalargewesternhcccohort AT nageldorothea prognosisofpatientswithhepatocellularcarcinomavalidationandrankingofestablishedstagingsystemsinalargewesternhcccohort AT sappljulia prognosisofpatientswithhepatocellularcarcinomavalidationandrankingofestablishedstagingsystemsinalargewesternhcccohort AT opdenwinkelphilip prognosisofpatientswithhepatocellularcarcinomavalidationandrankingofestablishedstagingsystemsinalargewesternhcccohort AT lamerzrolf prognosisofpatientswithhepatocellularcarcinomavalidationandrankingofestablishedstagingsystemsinalargewesternhcccohort AT zechchristophj prognosisofpatientswithhepatocellularcarcinomavalidationandrankingofestablishedstagingsystemsinalargewesternhcccohort AT straubgundula prognosisofpatientswithhepatocellularcarcinomavalidationandrankingofestablishedstagingsystemsinalargewesternhcccohort AT nickelthomas prognosisofpatientswithhepatocellularcarcinomavalidationandrankingofestablishedstagingsystemsinalargewesternhcccohort AT rentschmarkus prognosisofpatientswithhepatocellularcarcinomavalidationandrankingofestablishedstagingsystemsinalargewesternhcccohort AT stieberpetra prognosisofpatientswithhepatocellularcarcinomavalidationandrankingofestablishedstagingsystemsinalargewesternhcccohort AT gokeburkhard prognosisofpatientswithhepatocellularcarcinomavalidationandrankingofestablishedstagingsystemsinalargewesternhcccohort AT kolligsfrankt prognosisofpatientswithhepatocellularcarcinomavalidationandrankingofestablishedstagingsystemsinalargewesternhcccohort |